Authorization

DGAP-Adhoc: MOLOGEN AG - Capital Increase from Authorized Capital

DGAP-Ad-hoc: MOLOGEN AG / Key word(s): Capital Increase/Corporate Action


MOLOGEN AG - Capital Increase from Authorized Capital


13-March-2019 / 12:01 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.



Publication of an insider information pursuant to Section 17 of the regulation (EU) No. 596/2014

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

MOLOGEN AG - Capital Increase from Authorized Capital

Berlin, 13 March 2019 - The Executive Board of MOLOGEN AG (ISIN DE000A2LQ900, SIN A2L Q90) (the "Company") today resolved, with the approval of the Company's Supervisory Board, a capital increase with indirect subscription rights for shareholders, exercising the Company's authorized capital (Authorized Capital 2018) pursuant to Section 4 no. 3 of its articles of association. The Company's share capital is to be increased from currently EUR 10,061,102 by up to EUR 2,012,220 to up to EUR 12,073,322 through the issue of up to 2,012,220 new ordinary bearer shares of the Company, with each such share representing a notional value of the Company's share capital of EUR 1.00 (the "New Shares") against contributions in cash. The New Shares shall be entitled to dividends from 1 January 2018.

The subscription rights will be publicly offered to the Company's existing shareholders in accordance with the terms of the subscription offer (Bezugsangebot) and without a prospectus pursuant to section 3 para. 2 sentence 1 no. 5 and section 4 para. 2 sentence 1 of the German Securities Prospectus Act (Wertpapierprospektgesetz) in conjunction with art. 1 para. 5 subpara. 1 lit. a) of Regulation (EU) 2017/1129. Consequently, the Company will not prepare and publish a securities prospectus in relation to the rights offering and the New Shares. Before deciding to exercise their subscription rights, shareholders are recommended to inform themselves fully and to, for example, read the Company's financial reports which are available on the Company's website at www.mologen.com. However, the Company's financial statements 2018 will only be available after the completion of the capital increase.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Март 2019    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
25262728293031